Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't know Maciste, but I'm going to guess that we have two "characteristics" in common:
1. We're invested in AUPH, and hope (and expect) a very positive outcome.
2. We recognize the "characteristics" of gadflies (you know: vapid, pointlessly annoying, persistent, prone to posting for no apparent reason, ... etc.)
Are you talking about THIS company (Aurinia)?? Doesn't seem company specific at all. I've seen that ... ah ... whatever, on every board almost every day!
What sort of "news" do you want. As far as I know the P3 clinical trial is ongoing, and pretty soon we should be getting actual news (I expect it's going to be good!).
Gee, ... I didn't even know that AUPH was "mismanaged"!!!! I thought we're on our way to approval and all the good things that follow.
My confidence in the group's proposals is somewhat undermined by (7):
Jess, you must be a fast reader, the "researcher" will have your post whacked very quickly if he can. Another of his many charming characteristics.
Pluristem has NOT been delisted, it will not be delisted! No reason to worry about it!
Pure fear-mongering (nobody takes it seriously, except maybe Mikey)
Wisdom from "Auto1Eich999":
DEAD MONEY…. Bwahahawahahawa…. (Auto1)
PATHETIC (Eich)
I'm eagerly awaiting the Pluristem archeologist (Scott999) to share some interesting stuff from 15 years ago, ... he's been digging and digging, I'm sure he'll come up with something interesting (I mean if you're interested in the irrelevant, the pointless, the insignificant, ... if you'd rather look at whatever he unearths, and not the current clinical studies, conducted by some of the most competent experts in their various medical specialties).
But, I would like to compliment the first 2/3 rd of the troika, they've reached blissful brevity, they've managed to reduce and distill their analysis of Pluristem to "PATHETIC" and "Bwahahawahahawa".
I find the latter to be particularly on point, Bwahahawahahawa!
"Clay Trader" is just noise, sort of like someone on this board who thinks he's a "researcher"!
Unfortunately, stock discussion boards are like carrion to hyenas, irresistable!
Anyone who considers "Clay Trader" as a source of significant investment advice should be put under the guardianship of a relative who's willing to assume fiduciary responsibility on his behalf.
Hi Melon4head,
Very interesting links. I think it's very unlikely that these patients were one-off cases. The evidence is very compelling. The diseases are very complex, as is the body's reaction to PLX-PAD, so it seems very likely that the medicine pushes all the right buttons (MOA) when restoring vascular function.
Thanks,
zzaatt.
Hi Allo, I think your response is very reasonable in terms of looking at JaySrini's posts. That's why I do not assert that it's untrue, it's just that one has to be somewhat skeptical about anything posted on a public board (just look at the output of "AutoEich999", if you have the stomach for it).
In any case, JaySrini's situation could well be one more confirmation of what we know already, that PLX-PAD does have a dramatic effect in healing terrible, debilitating vascular injury, we actually have published pictures that indicate that. It's a pleasure to have invested in a company that will very likely have a major (in some cases lifesaving) impact on millions of patients, and coincidentally, provide investors with an excellent ROI.
Best Regards,
zzaatt.
I do believe that JaySrini's story is eminently feasible, we have seen evidence that gives us hope that PLX-PAD does have a therapeutic effect.
But, I do have my skepticism about the specifics. First, MGH is a top notch hospital, I know three physicians there, they're all involved in research, and not one of them would turn down an opportunity to work with the latest developments in their own area of interest. I just don't see a vascular surgeon not jump at the opportunity to get involved in, or at least follow a patient who's gotten a bite at this apple.
I also find it odd that MGH would keep a patient in the hospital against his will ("to make money"). I don't believe they can legally do that, even if they were inclined to do so.
If all of this is real, I certainly wish Jay the best and continued healing, but I remain skeptical, ... just a gut level reaction (in addition to the specifics above). BTW, Tuft's involvement in this trial is public knowledge.
I also think that doctors know how to spell "trial":
"We don't do that trail, and I'm not necessarily a big believer in these, but happy to support you in your exploration."
I don't want to impersonate Inspector Poirot, but the doctor's misspelling matches that of JaySrini's other uses of that word.